Joseph E. Payne, President & CEO, Chairman of the Board
Padmanabh Chivukula, CSO & COO, Director of the Board
Craig Willett, Director of the BoardCraig is the President and CEO of Voice of the Entrepreneur, Inc. providing start up coaching services to the next generation of entrepreneurs. He is the past President and CEO of UTAZ Development Corporation, the innovator of "Own For Less Than Rent" office space. Craig has demonstrated his ability to assemble capital and lead development teams to extraordinary success as reflected in the success of the nearly $700 million of projects to which he has offered his vision and leadership. He is also a real estate broker and CPA and holds bachelor's and master's degrees in accounting from Brigham Young University. As the founder of an accounting firm specializing in business and real estate tax issues he is a recognized business and tax authority testifying in both houses of Congress and has been quoted in the New York Times, the Washington Post, and the Wall Street Journal. Craig was also a founding director of Capital Community Bank. He is a Founder in the Brigham Young University Center for Entrepreneurship. He has served on many community development boards most recently Banner Children's Hospital Capital Campaign Board.
Stuart Collinson, Director of the BoardDr. Stuart Collinson is a partner at Forward Ventures and also the Executive Chairman of Tioga Pharmaceuticals, Inc. Previously he was Chairman, Chief Executive Officer and President of Aurora Biosciences Corp. (acquired by Vertex Pharmaceuticals Inc.). Before Aurora, Dr. Collinson was Chief Executive Officer of Andaris Limited (acquired by Quadrant, now part of Perrigo). He held senior management positions at GlaxoWellcome plc (now GlaxoSmithKline plc) and Baxter International Inc., and was a consultant with The Boston Consulting Group. Dr. Collinson was previously a director of Affinium Pharmaceuticals, Inc. (acquired by Debiopharma Group), Cabrellis Pharmaceuticals Corp. (acquired by Pharmion Corp., now part of Celgene Corp.), Conforma Therapeutics Corp. (acquired by BiogenIdec, Inc.), GeneOhm Sciences, Inc. (acquired by Becton, Dickinson and Company), NovaCardia, Inc. (acquired by Merck & Co, Inc.), and Proprius Pharmaceuticals, Inc. (acquired by Cypress Bioscience, Inc.), and Vertex Pharmaceuticals Inc. Dr. Collinson received an M.B.A. from Harvard Business School and a Ph.D. in Physical Chemistry from the University of Oxford.
Craig is the President and CEO of Voice of the Entrepreneur, Inc. providing start up coaching services to the next generation of entrepreneurs.
Dr. Stuart Collinson is a partner at Forward Ventures and also the Executive Chairman of Tioga Pharmaceuticals, Inc.
May 15, 2017
Ernst & Young Selected Arcturus as the Finalists for the Entrepreneur Of The Year 2017 Award® in San Diego
April 29, 2017
Arcturus Therapeutics to Present at the TIDES--Oligonucleotides and Peptide Therapeutics, on Unlocked Nucleomonomer Agent (UNA) Oligomer System, Challenges and Opportunities
April 10, 2017
Arcturus Therapeutics is Selected by Ernst and Young as Semifinalists for the Entrepreneur Of The Year® 2017 Award in San Diego